U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929481) titled 'Screening With a DNA Blood Test to Address Colorectal Cancer Inequities' on March 16.
Brief Summary: Colorectal cancer (CRC) screening participation is suboptimal and associated with inequities in CRC outcomes by race/ethnicity and socioeconomic position. A novel, cell free DNA (cfDNA) blood test has potential to increase participation, but has not been studied in groups at highest risk for adverse CRC outcomes. Among patients age-eligible for colorectal cancer screening, not up-to-date, we propose a 2-arm, pragmatic, randomized controlled trial comparing offers of standard screening options (at home fecal immunochemical test (FIT)...